Published in Psychiatry Res on November 11, 2012
Predictors of mild cognitive impairment in early-stage Parkinson's disease. Dement Geriatr Cogn Dis Extra (2013) 0.95
Recent imaging advances in neurology. J Neurol (2015) 0.81
Bayesian networks in neuroscience: a survey. Front Comput Neurosci (2014) 0.80
Distinguishing Parkinson's disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks. Front Comput Neurosci (2015) 0.80
Classification of pallidal oscillations with increasing parkinsonian severity. J Neurophysiol (2015) 0.79
Applying Naive Bayesian Networks to Disease Prediction: a Systematic Review. Acta Inform Med (2016) 0.75
Bayesian predictive modeling based on multidimensional connectivity profiling. Neuroradiol J (2015) 0.75
A review of feature selection techniques in bioinformatics. Bioinformatics (2007) 13.51
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Machine learning in bioinformatics. Brief Bioinform (2006) 2.86
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry (2003) 2.61
Filter versus wrapper gene selection approaches in DNA microarray domains. Artif Intell Med (2004) 2.46
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet (2009) 2.16
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol (2009) 1.96
Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke (2004) 1.85
Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord (2007) 1.73
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Alzheimer Dis Assoc Disord (2008) 1.63
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord (2009) 1.51
Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord (2008) 1.45
Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy. Clin Endocrinol (Oxf) (2013) 1.43
Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord (2008) 1.33
Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging. Int J Geriatr Psychiatry (2003) 1.32
Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis (2012) 1.26
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol (2011) 1.23
Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol (2005) 1.18
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord (2011) 1.15
Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J Hepatol (2010) 1.08
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord (2009) 1.06
Feature selection in Bayesian classifiers for the prognosis of survival of cirrhotic patients treated with TIPS. J Biomed Inform (2005) 1.05
Identification of a biomarker panel for colorectal cancer diagnosis. BMC Cancer (2012) 1.02
Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects. Psychiatry Res (2010) 1.02
Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening. Mov Disord (2008) 1.01
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord (2005) 1.01
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord (2010) 1.01
Cognitive impairment in nondemented Parkinson's disease. Mov Disord (2011) 1.01
Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease. PLoS One (2013) 1.01
Comparison between supervised and unsupervised classifications of neuronal cell types: a case study. Dev Neurobiol (2011) 1.00
Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study. Arch Neurol (2002) 1.00
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity. J Neurol (2009) 0.99
Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain. Cerebrovasc Dis (2004) 0.97
Detecting reliable gene interactions by a hierarchy of Bayesian network classifiers. Comput Methods Programs Biomed (2008) 0.95
Altered default network resting state functional connectivity in patients with a first episode of psychosis. Schizophr Res (2012) 0.94
Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res (2010) 0.94
Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study. Mov Disord (2009) 0.94
Machine learning: an indispensable tool in bioinformatics. Methods Mol Biol (2010) 0.93
Predicting citation count of Bioinformatics papers within four years of publication. Bioinformatics (2009) 0.93
Models and simulation of 3D neuronal dendritic trees using Bayesian networks. Neuroinformatics (2011) 0.92
Three-dimensional spatial distribution of synapses in the neocortex: a dual-beam electron microscopy study. Cereb Cortex (2013) 0.92
Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J Neurol (2003) 0.92
Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale. Parkinsonism Relat Disord (2013) 0.90
Rapidly progressive dementia: experience in a tertiary care medical center. Alzheimer Dis Assoc Disord (2012) 0.90
Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol (2006) 0.90
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J Neurol (2013) 0.90
The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease. Mov Disord (2014) 0.89
A review of estimation of distribution algorithms in bioinformatics. BioData Min (2008) 0.89
Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology (2004) 0.89
Usefulness of p300 in subjective memory complaints: a prospective study. J Clin Neurophysiol (2005) 0.89
Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Mov Disord (2010) 0.88
A partially supervised classification approach to dominant and recessive human disease gene prediction. Comput Methods Programs Biomed (2007) 0.88
Prioritization of candidate cancer genes--an aid to oncogenomic studies. Nucleic Acids Res (2008) 0.88
Diagnosis and management of essential tremor and dystonic tremor. Ther Adv Neurol Disord (2009) 0.87
Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer's disease. Dement Geriatr Cogn Disord (2004) 0.86
Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. J Psychiatry Neurosci (2013) 0.86
Routine neurophysiologic tremor analysis as a diagnostic tool for essential tremor: a prospective study. J Clin Neurophysiol (2004) 0.86
Markov blanket-based approach for learning multi-dimensional Bayesian network classifiers: an application to predict the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson's Disease Questionnaire (PDQ-39). J Biomed Inform (2012) 0.86
Unveiling relevant non-motor Parkinson's disease severity symptoms using a machine learning approach. Artif Intell Med (2013) 0.86
Comorbid Asperger and Tourette syndromes with localized mesencephalic, infrathalamic, thalamic, and striatal damage. Dev Med Child Neurol (2003) 0.86
Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing. J Neurosci (2014) 0.86
Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study. Mov Disord (2007) 0.85
Bayesian classification for the selection of in vitro human embryos using morphological and clinical data. Comput Methods Programs Biomed (2008) 0.85
A new measure for gene expression biclustering based on non-parametric correlation. Comput Methods Programs Biomed (2013) 0.85
Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br J Psychiatry (2013) 0.85
Bayesian model averaging of naive Bayes for clustering. IEEE Trans Syst Man Cybern B Cybern (2006) 0.85
Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov Disord (2013) 0.84
PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease. Mov Disord (2010) 0.84